These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 7805731

  • 1. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
    van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T.
    Eur J Immunol; 1994 Dec; 24(12):3038-43. PubMed ID: 7805731
    [Abstract] [Full Text] [Related]

  • 2. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P.
    Cancer Res; 1997 Feb 15; 57(4):735-41. PubMed ID: 9044853
    [Abstract] [Full Text] [Related]

  • 3. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.
    van der Bruggen P, Szikora JP, Boël P, Wildmann C, Somville M, Sensi M, Boon T.
    Eur J Immunol; 1994 Sep 15; 24(9):2134-40. PubMed ID: 7522162
    [Abstract] [Full Text] [Related]

  • 4. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P.
    J Immunol; 1999 Sep 01; 163(5):2928-36. PubMed ID: 10453041
    [Abstract] [Full Text] [Related]

  • 5. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT.
    Clin Cancer Res; 1996 Jan 01; 2(1):87-95. PubMed ID: 9816095
    [Abstract] [Full Text] [Related]

  • 6. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
    Huang LQ, Brasseur F, Serrano A, De Plaen E, van der Bruggen P, Boon T, Van Pel A.
    J Immunol; 1999 Jun 01; 162(11):6849-54. PubMed ID: 10352307
    [Abstract] [Full Text] [Related]

  • 7. Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro.
    Fujie T, Tanaka F, Mori M, Takesako K, Sugimachi K, Akiyoshi T.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2425-30. PubMed ID: 9815643
    [Abstract] [Full Text] [Related]

  • 8. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.
    Takahashi T, Irie RF, Morton DL, Hoon DS.
    Cell Immunol; 1997 Jun 15; 178(2):162-71. PubMed ID: 9225007
    [Abstract] [Full Text] [Related]

  • 9. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
    Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF.
    J Immunol; 1991 Mar 01; 146(5):1692-9. PubMed ID: 1671580
    [Abstract] [Full Text] [Related]

  • 10. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
    Sensi M, Pietra G, Molla A, Nicolini G, Vegetti C, Bersani I, Millo E, Weiss E, Moretta L, Mingari MC, Anichini A.
    Int Immunol; 2009 Mar 01; 21(3):257-68. PubMed ID: 19181932
    [Abstract] [Full Text] [Related]

  • 11. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E.
    J Immunol; 1995 Mar 01; 154(5):2257-65. PubMed ID: 7868898
    [Abstract] [Full Text] [Related]

  • 12. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
    Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde KH, Boon T.
    Eur J Immunol; 1994 Mar 01; 24(3):759-64. PubMed ID: 8125142
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine.
    Hu X, Chakraborty NG, Sporn JR, Kurtzman SH, Ergin MT, Mukherji B.
    Cancer Res; 1996 Jun 01; 56(11):2479-83. PubMed ID: 8653680
    [Abstract] [Full Text] [Related]

  • 14. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T, Irie RF, Nishinaka Y, Hoon DS.
    Clin Cancer Res; 1997 Aug 01; 3(8):1363-70. PubMed ID: 9815820
    [Abstract] [Full Text] [Related]

  • 15. Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen.
    Zhu B, Chen Z, Cheng X, Lin Z, Guo J, Jia Z, Zou L, Wang Z, Hu Y, Wang D, Wu Y.
    Clin Cancer Res; 2003 May 01; 9(5):1850-7. PubMed ID: 12738743
    [Abstract] [Full Text] [Related]

  • 16. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.
    van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI.
    Eur J Immunol; 1996 Aug 01; 26(8):1683-9. PubMed ID: 8765006
    [Abstract] [Full Text] [Related]

  • 17. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.
    Hao X, Shao Y, Ren X, Liu H, Xu Q, Li H, Zhang P, An X, Ren B.
    J Cancer Res Clin Oncol; 2002 Sep 01; 128(9):507-15. PubMed ID: 12242516
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.
    Dutoit V, Rubio-Godoy V, Dietrich PY, Quiqueres AL, Schnuriger V, Rimoldi D, Liénard D, Speiser D, Guillaume P, Batard P, Cerottini JC, Romero P, Valmori D.
    Cancer Res; 2001 Aug 01; 61(15):5850-6. PubMed ID: 11479225
    [Abstract] [Full Text] [Related]

  • 19. Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors.
    Corbière V, Nicolay H, Russo V, Stroobant V, Brichard V, Boon T, van der Bruggen P.
    Tissue Antigens; 2004 May 01; 63(5):453-7. PubMed ID: 15104676
    [Abstract] [Full Text] [Related]

  • 20. The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.
    Peiper M, Goedegebuure PS, Linehan DC, Ganguly E, Douville CC, Eberlein TJ.
    Eur J Immunol; 1997 May 01; 27(5):1115-23. PubMed ID: 9174600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.